News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
103 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32017)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Business
Nexstim Plc Appoints Steve Beller as Vice President and General Manager, North America
Mr. Beller will join the Nexstim Management Team and report to CEO Martin Jamieson.
December 1, 2017
·
3 min read
Drug Development
VM BioPharma Announces Initiation of Hepatocyte Growth Factor to Improve Functioning in PAD, HI-PAD, Study of VM202 in Peripheral Artery Disease
VM BioPharma today announced the launch of the HI-PAD study, a trial to investigate the effect of VM202, a DNA plasmid encoding HGF, on mobility and calf perfusion in older adults with PAD.
December 1, 2017
·
6 min read
Business
Basilea Snags Extended $226M+ Antifungal Deal With Pfizer
Basilea eligible to receive additional upfront and milestone payments of up to USD 226 million and mid-teen royalties on sales.
December 1, 2017
·
5 min read
Pharm Country
Tauriga Sciences Fully Repays $45,000 8% Face Value Convertible Debenture Issued to GS Capital Partners, LLC for One Time Cash Payment of $61,664.79
This convertible debenture, which was issued by the Company on May 30, 2017, has been fully repaid for a one-time cash payment of $61,664.79 USD.
December 1, 2017
·
3 min read
Polyganics Awarded €1.2 Million to Complete Clinical Development of Dura Sealant Patch
The grant, together with contributions from the city and province of Groningen, totals EUR 1.2 million.
December 1, 2017
·
1 min read
MBS Selects AMPLITECH to Launch NEXTGENPCR in France and Switzerland
Described as the first real advance in thermal cycling for 15 years, the NEXTGENPCR dramatically slashes current time-consuming DNA amplification from hours to minutes.
December 1, 2017
·
2 min read
Business
Athenex Announces Planned Retirement of Chief Financial Officer Nick Riehle
Mr. Riehle intends to retire from full time employment in order to spend more time with his family.
December 1, 2017
·
4 min read
Business
Aphios is Developing a Platform for the Delivery of siRNA-based Therapeutics Towards an HIV Cure
The nanotechnology platform is initially targeting a cure for human immunodeficiency virus (HIV) using specific small interfering RNA (siRNA) molecules.
December 1, 2017
·
2 min read
LightIntegra Secures $3.5M Round of Financing
“The financing allows our company to generate working capital while maintaining its existing ownership structure.”
December 1, 2017
·
1 min read
Policy
Roche Supports FDA Communication About Potential for Biotin Interference With Lab Tests
Roche supports the recommendation issued by the FDA that patients should report if they are taking biotin as a supplement to their health care providers as part of their patient profile
December 1, 2017
·
4 min read
Previous
3 of 11
Next